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Are Outcomes Different?
The thesis that women are different from men is not argued in any more important
venue than the surgical theatre. The questions of whether and why women have
higher probabilities of poor outcomes after coronary artery bypass grafting (CABG)
have been repeatedly asked. A common denominator among published investiga-
tions is that the preoperative profile of the female patient is vastly different from that
of the male patient.
Some risk factors traditionally associated with increased morbidity and mortality
after CABG are more commonly represented in the preoperative profile of the
female patient. The extent to which these factors explain gender differences,
however, varies among studies. Some investigations report higher adjusted mortality
for women,1-4 whereas others, with application of adjustment strategies, report
similar in-hospital mortality between women and men,5-9 and yet others report
similar postoperative mortality for women and men despite differences in baseline
characteristics.10-13
How can multiple studies examining the role of gender in surgical outcomes lead
to such varied conclusions despite similar analyses of observational databases? If
one structures the question correctly, collects the necessary data, and performs the
appropriate analysis, one should expect a consistent answer. On the subject of
gender, is the question structured to be answered, is there some unmeasured or
unknown biologic variable or process-of-care decision in the perioperative period




Understanding the strengths and limitations of experimental versus observational
study designs allows for a better understanding of the application of data analysis
methods. The randomized controlled trial (RCT) is considered the gold standard
when examining outcomes between groups. Specific design elements of the RCT
include uniform selection and management of patients under controlled conditions
in tertiary care centers. This reduces bias associated with the selection of patients
and reduces the variability that results when examining nonhomogeneous popula-
tions by balancing known and unknown confounding variables.14-16 While reducing
variability, these design elements might limit the ability to generalize the results of
an RCT for real-world clinical practice. Homogeneous samples of patients might not
be reflective of a patient population, thereby limiting treatment efficacy in routine
clinical practice.14,16,17
On the question of gender, however, an RCT is impossible: one cannot random-
ize patients to sex. Thus observational databases form the basis for a majority of
published investigations. Concato and colleagues18 challenged the hierarchical
approach to research study designs that consider the observational study to be
methodologically inferior to the RCT. This challenges the criticism that all obser-
vational studies are weaker or misleading by demonstrating that well-designed
observational studies do not systematically overestimate the magnitude of the
effects of treatments compared with an RCT. However, data collected for observa-
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tional studies are uncontrolled observations from clinical
practice and are therefore prone to selection biases that
would be eliminated by the randomization process.17,19
Among other concerns are a lack of standardized defini-
tions, richness versus paucity of details on the clinical
severity of the comorbid conditions, incompleteness of data
collection methods, and a failure to capture physicians’
choices regarding process-of-care decisions that are not
random. Furthermore, there are temporal trends that occur
with advances in surgical technique and medical manage-
ment that might differentially affect subgroups under inves-
tigation.16,20
Adjustment Strategies
How we analyze the data might be the most important
source of variability in what has been concluded about the
influence of gender on outcomes after CABG. The investi-
gative process among many of the studies generally begins
with an examination of patient characteristics by gender,
followed by risk adjustment strategies to control for gender
differences in preoperative risk factors to determine whether
female gender is independently associated with poorer prog-
nosis. Although this is an accepted approach for analysis,
there are a number of issues in the statistical techniques
used that might explain, in part, the different results ob-
tained in this literature.
Model-free techniques and multivariable modeling.
Model-free or statistical modeling techniques are used to
adjust for influential variables among patient groups being
compared. Many investigations have used model-free tech-
niques, such as matching and subclassification, in an at-
tempt to control for a single or a few factors in the analysis.
Others have applied various modeling techniques that
model postoperative morbidities or mortality as a function
of gender, adjusting for a number of covariables.21 The set
of covariables selected in the final model is often different
across published studies, and this fact might in part explain
the variability of results obtained. Factors that could influ-
ence variable selection for the final model include the re-
searcher’s approach to missing or incorrect data, differences
in data coding, and the presence of correlated data. Addi-
tional issues that might lead to differences in the final model
include the omission of important predictor variables, vio-
lations of model assumptions, improper imputation meth-
ods,22,23 and differences in the approach for variable selec-
tion for inclusion in the final model.22 Furthermore, there
are investigations that omit variables that are not univari-
ably associated with outcome. This might exclude lurking
variables that relate to outcome only when other variables
that mask their significance are accounted for in the analy-
sis.24,25 The application of traditional matching or stratifi-
cation techniques is ultimately limited by the number of
covariates that can be used for matching or stratification.26
For example, if a data set contains 200 patients who need to
be matched on age, gender, surgical procedure, and a num-
ber of comorbid conditions, there might not be enough
patients in the sample to match or to stratify on each of the
important variables. In addition, regression techniques are at
risk of overfitting or underfitting the model if the data
contain too few outcome events relative to the number of
covariates used for adjustment in the model.27 If dealing
with a data set of 500 patients who are followed for 12
months, with only 3 deaths occurring during the follow-up
period, baseline variables associated with mortality are de-
termined from only a few observations. The regression
coefficients for the baseline variables might not be accurate
or might be estimated with low precision because of the
paucity of outcome events. Underfitting a model can occur
when the power to detect important relationships is low.
Consider those same 500 patients who are now followed up
for a specific event over a 10-year period, with the devel-
opment of the event occurring in only 4 patients. Because
the outcome events are sparse, an association of risk be-
tween a baseline characteristic and a particular outcome
would probably be undetectable. Thus the scarcity of out-
come events could lead to ambiguous results.27 Finally, few
investigations provide a measure of model reliability, such
as bootstrap aggregation techniques.28
Propensity modeling techniques. Propensity modeling
allows us to examine patients undergoing CABG from a
different statistical vantage point to gain novel insights into
the role of gender on postoperative outcomes.29 Both pro-
pensity score methodology and the parametric approach can
provide inferences about causal effects in observational
studies.30 However, propensity score methods do not share
the same limitations as conventional matching, stratifica-
tion, or multivariable regression techniques in that propen-
sity modeling is not limited by the number of background
covariates that can be used. The propensity score provides a
summary of the entire spectrum of covariates with one
function of the covariates for the individual patient.31,32 It is
calculated by predicting group membership from the entire
spectrum of background characteristics with the use of
logistic regression or discriminant analysis. Outcome vari-
ables have no role in the prediction of group membership
when calculating the propensity score.32 The score is cal-
culated by summating the product of the coefficient for each
variable by the specific value for each variable. The inter-
cept is then added to this value, resulting in the propensity
score for that patient. The propensity score is then the single
summarized confounding covariate that can be used for
matching, subclassification, or multivariable adjustment.21
Patients then matched on propensity scores have a balance
in the distribution of covariates, allowing for equivalent
comparisons between the groups under investigation.30 A
recent observational investigation of isolated patients un-
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dergoing CABG applied propensity modeling techniques to
examine the role of gender on postoperative morbidity and
mortality. Women and men matched on propensity scores
had a similar distribution of preoperative comorbid condi-
tions. Most importantly, there was no statistically significant
difference in the occurrence of postoperative mortality
among the propensity matched pairs of women and men.29
Of note, only 26% of patients were able to be matched on
propensity scores. The ability to match only 26% is reflec-
tive of the vastly dissimilar preoperative profiles of women
and men undergoing CABG. This investigation demon-
strates that, without taking into consideration the dissimilar
preoperative profiles of women and men, the mortality
results of the same data set can yield different results. In this
study, when a standard multivariable logistic regression
model for postoperative mortality is applied to the entire
data set, irrespective of matching, female gender was sig-
nificantly predictive of postoperative mortality. A compar-
ison of the distribution of propensity scores among the
women and men revealed little overlap in scores. Nothing in
standard regression diagnostics will display the lack of
overlap among groups under investigation with regard to the
distribution of covariates. When the overlap is limited, it is
difficult for the data set to support causal conclusions.31
Propensity methods, similar to all nonrandomized compar-
isons, are limited by the potential for omitted confounding
variables that might bias the outcome results.30
Is it Process-of-Care Decisions?
Variations in process-of-care decisions in the perioperative
period might be contributing to the gender differences in
observed outcomes among the published investigations be-
cause such variations can influence patient outcomes. Many
operative variables, such as cardioplegia techniques, com-
pleteness of myocardial revascularization, and decisions to
transfuse blood products and administer inotropic agents,
are often unmeasured or uncontrolled variables.
There is substantial variability in the perioperative pro-
cess of care across different institutions and surgical teams.
For example, the decision to transfuse a patient periopera-
tively in many cases is based on anecdotal practices of the
particular cardiac team and institution. In a recent observa-
tional investigation on the role of gender in the outcomes of
CABG, 76% of women were transfused red blood cells in
the operative and postoperative periods.29 Furthermore,
among the propensity matched pairs of women and men,
women were transfused red blood cells more frequently
than men despite similar preoperative blood volumes, he-
matocrit levels, body surface areas, and rates of re-explora-
tion for bleeding.29 The process-of-care decision to trans-
fuse red blood cells is an unaddressed variable in many of
the investigations of gender on outcomes after CABG.
Another process-of-care issue that might influence pa-
tient outcomes and therefore gender differences in outcomes
is the decision to administer inotropic agents in the periop-
erative period. It has been reported that women require more
inotropic agents13,29 and have a greater occurrence of car-
diac morbidity postoperatively, despite equal or better pre-
served left ventricular function and equal or less extensive
coronary artery disease preoperatively.3,11,29
Is there an unmeasured process-of-care decision in the
operating room the result of which is the perception of
myocardial injury in the postoperative period? Could it be
related to the more frequent occurrence of blood transfu-
sions in women or to different approaches to myocardial
protection or completeness of myocardial revascularization?
Process-of-care decisions are being made that we do not
fully understand and might be contributing to the problem
and the apparent differences in outcomes. In these instances,
although we are clearly managing women differently from
men, there is not a sufficient scientific basis to justify these
different treatment approaches.
Is it Biologic Mystique?
Biologic variability among women and men with regard to
the pharmacokinetic and pharmacodynamic profiles for a
number of drugs has been demonstrated. However, there is
an insufficient amount of information to determine whether
these differences in response influence outcomes.33 Is the
demonstrated need for prolonged postoperative ventilatory
support in women after CABG29,34 the result of gender
differences in the pharmacodynamic or pharmacokinetic
response to drugs used in the perioperative period? In gen-
eral, narcotic, benzodiazepine, and muscle relaxant drugs
given in the perioperative period are arbitrarily dosed with-
out taking into account body weight, unless as part of a
clinical trial. The fact that women receive equivalent doses
of medications as men without considering ideal body
weight might contribute to the observed gender differences
in postoperative ventilatory support after CABG. Certainly
the influence of hormones, stages of the menstrual cycle,
amount and distribution of adipose tissue, and pharmaco-
dynamic and pharmacokinetic differences between women
and men in response to perioperative medications requires
further investigation.
Answers?
Variable application of statistical techniques and unmea-
sured factors, particularly process-of-care decisions, might
indeed have a strong influence on the variability in the
reported results that have been attributed to gender differ-
ences in outcome. The effect of unaccounted biologic fac-
tors among women and men begs for further investigation.
Although the superiority of one sex can (and will) be
argued, we should make all the possible efforts, scientifi-
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cally and technologically, so that equal operative outcomes
can be obtained in women and men.
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